J.P. Morgan Maintains Overweight On CME Group (CME)

J.P. Morgan is maintaining its Overweight rating on CME Group Inc. CME, after meeting with company management to discuss earnings prospects. It has a $370 price target on shares. In the research report, J.P. Morgan notes, "Opportunities increase conviction in 2011 consensus—valuation more compelling. We believe the opportunities discussed above can bridge earnings growth somewhat until the global economy recovers and rates rise. We are reinvigorated in our recommendation of CME following a broken thesis, and we thus maintain our Overweight rating and $370 target." Shares of CME Group gained .97% on Friday to close at $264.90, a gain of $2.55.